Treatment of EMT6 tumor-bearing mice with either the anti-mouse PD-L1 monoclonal antibody 6E11 or the IRE1α inhibitor G9668 partially impaired EMT6 tumor progression (Fig. 7 A; and Fig. S6, C and D). This evidence concerns the gene CD274 and neoplasm.